Table 2.
All (n = 40) | Control (n = 20) | hUC-MSC (n = 20) | P value | |
---|---|---|---|---|
Demographics | ||||
Sex, n (%) | 1.000A | |||
Male | 28 (70.0%) | 14 (70.0%) | 14 (70.0%) | |
Female | 12 (30.0%) | 6 (30.0%) | 6 (30.0%) | |
Age, years, mean ± SEM | 4.293 ± 0.397 | 4.755 ± 0.644 | 3.830 ± 0.459 | 0.249B |
History of preterm labor, n (%) | 16 (40.0%) | 7 (35.0%) | 9 (45.0%) | 0.519A |
Birth weight, kg, mean ± SEM | 2.320 ± 0.042 | 2.395 ± 0.053 | 2.245 ± 0.062 | 0.072B |
History of rehabilitation, n (%) | 11 (27.5%) | 6 (30.0%) | 5 (25.0%) | 0.723A |
MRI findings | ||||
Brain maldevelopments, n (%) | 23 (57.5%) | 13 (65.0%) | 10 (50.0%) | 0.337A |
Cerebromalacia, n (%) | 6 (15.0%) | 3 (15.0%) | 3 (15.0%) | 0.658C |
Focal ischemia, n (%) | 1 (2.5%) | 0 | 1 (5.0%) | 1.000D |
Corpus callosum agenesis, n (%) | 1 (2.5%) | 0 | 1 (5.0%) | 1.000D |
Normal, n (%) | 9 (22.5%) | 4 (20.0%) | 5 (25.0%) | 1.000C |
Abbreviations: hUC-MSC human umbilical cord-derived mesenchymal stem cell, MRI magnetic resonance imaging
AP value was calculated by χ2 test
BP value was calculated by one-way ANOVA
CP value was calculated by correction χ2 test
DP value was calculated by Fisher’s exact test